Tumour-associated mesenchymal stem/stromal cells: Emerging therapeutic targets

Yufang Shi, Liming Du, Liangyu Lin, Ying Wang

Research output: Contribution to journalReview articlepeer-review

301 Scopus citations


Mesenchymal stem cells, also known as mesenchymal stromal cells (MSCs), exist in many tissues and are known to actively migrate to sites of tissue injury, where they participate in wound repair. Tumours can be considered "wounds that never heal" and, in response to cues from a tumour, MSCs are continuously recruited to and become integral components of the tumour microenvironment. Recently, it has become apparent that such tumour-associated MSCs (TA-MSCs) have an active role in tumour initiation, promotion, progression and metastasis. In this Review, we discuss recent advances in our understanding of the pathogenic role of TA-MSCs in regulating the survival, proliferation, migration and drug resistance of tumour cells, as well as the influence of MSCs on the immune status of the tumour microenvironment. Moreover, we discuss therapeutic approaches that target TA-MSC upstream or downstream modulators or use MSCs as vehicles for the delivery of tumoricidal agents. It is anticipated that new insights into the functions of TA-MSCs will lead to the development of novel therapeutic strategies against tumours.

Original languageEnglish (US)
Pages (from-to)35-52
Number of pages18
JournalNature Reviews Drug Discovery
Issue number1
StatePublished - Dec 29 2016

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Tumour-associated mesenchymal stem/stromal cells: Emerging therapeutic targets'. Together they form a unique fingerprint.

Cite this